CHAD M ROBINS Insider Trading for September 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHAD M ROBINS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of CHAD M ROBINS for September 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 194,640 | |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 211,320 | |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 228,000 | |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.13 | 8,580 | 395,795 | 1,778,180 | 1.8 M to 1.8 M (-0.48 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.28 | 8,100 | 366,768 | 1,786,760 | 1.8 M to 1.8 M (-0.45 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.26 | 14,080 | 637,261 | 1,778,180 | 1.8 M to 1.8 M (-0.79 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 44.48 | 2,600 | 115,648 | 1,792,260 | 1.8 M to 1.8 M (-0.14 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 194,640 | |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 48.26 | 400 | 19,304 | 1,778,180 | 1.8 M to 1.8 M (-0.02 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 211,320 | |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 47.46 | 5,100 | 242,046 | 1,778,580 | 1.8 M to 1.8 M (-0.29 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 228,000 | |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.45 | 5,000 | 232,250 | 1,738,680 | 1.7 M to 1.7 M (-0.29 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.13 | 8,580 | 395,795 | 1,778,180 | 1.8 M to 1.8 M (-0.48 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.47 | 6,180 | 281,005 | 1,788,680 | 1.8 M to 1.8 M (-0.34 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.28 | 8,100 | 366,768 | 1,786,760 | 1.8 M to 1.8 M (-0.45 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.26 | 14,080 | 637,261 | 1,778,180 | 1.8 M to 1.8 M (-0.79 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 44.48 | 2,600 | 115,648 | 1,792,260 | 1.8 M to 1.8 M (-0.14 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 48.26 | 400 | 19,304 | 1,778,180 | 1.8 M to 1.8 M (-0.02 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 47.46 | 5,100 | 242,046 | 1,778,580 | 1.8 M to 1.8 M (-0.29 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.45 | 5,000 | 232,250 | 1,738,680 | 1.7 M to 1.7 M (-0.29 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.47 | 6,180 | 281,005 | 1,788,680 | 1.8 M to 1.8 M (-0.34 %) |
| Sep 18 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |